ATE229330T1 - Verwendung von n-acylvanillinamid-derivaten als agonisten der peripheren cannabinoid-cb1- rezeptoren - Google Patents

Verwendung von n-acylvanillinamid-derivaten als agonisten der peripheren cannabinoid-cb1- rezeptoren

Info

Publication number
ATE229330T1
ATE229330T1 AT99947394T AT99947394T ATE229330T1 AT E229330 T1 ATE229330 T1 AT E229330T1 AT 99947394 T AT99947394 T AT 99947394T AT 99947394 T AT99947394 T AT 99947394T AT E229330 T1 ATE229330 T1 AT E229330T1
Authority
AT
Austria
Prior art keywords
acylvanillinamide
derivatives
agonists
receptors
sub
Prior art date
Application number
AT99947394T
Other languages
English (en)
Inventor
Tiziana Bisogno
Valle Francesco Della
Petrocellis Luciano De
Marzo Vincenzo Di
Gabriele Marcolongo
Dominique Melck
Original Assignee
Innovet Italia Srl
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovet Italia Srl, Consiglio Nazionale Ricerche filed Critical Innovet Italia Srl
Application granted granted Critical
Publication of ATE229330T1 publication Critical patent/ATE229330T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
AT99947394T 1998-09-24 1999-09-21 Verwendung von n-acylvanillinamid-derivaten als agonisten der peripheren cannabinoid-cb1- rezeptoren ATE229330T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002064A IT1302264B1 (it) 1998-09-24 1998-09-24 Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi
PCT/EP1999/006980 WO2000016756A2 (en) 1998-09-24 1999-09-21 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors

Publications (1)

Publication Number Publication Date
ATE229330T1 true ATE229330T1 (de) 2002-12-15

Family

ID=11380754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99947394T ATE229330T1 (de) 1998-09-24 1999-09-21 Verwendung von n-acylvanillinamid-derivaten als agonisten der peripheren cannabinoid-cb1- rezeptoren

Country Status (8)

Country Link
US (1) US7244767B2 (de)
EP (1) EP1115392B1 (de)
AT (1) ATE229330T1 (de)
AU (1) AU6086099A (de)
DE (1) DE69904490T2 (de)
ES (1) ES2189489T3 (de)
IT (1) IT1302264B1 (de)
WO (1) WO2000016756A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516264T1 (de) 1999-07-07 2011-07-15 Innovet Italia Srl Kovalente derivate von mono- und dicarbonsäuren- alkanolamiden, die auf den cb2 cannabinoiden rezeptor wirken
AU2001261324A1 (en) * 2000-05-08 2001-11-20 Psoriasis Research Institute Psoriasis treatment
ES2174716B1 (es) * 2000-07-28 2004-08-01 Universidad Complutense De Madrid Nuevos derivados de acido araquidonico con afinidad por el transportador de anandamida.
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
TWI239942B (en) 2001-06-11 2005-09-21 Dainippon Pharmaceutical Co N-arylphenylacetamide derivative and pharmaceutical composition containing the same
ES2312643T5 (es) * 2001-07-18 2011-10-18 Unilever N.V. Composiciones para el tratamiento del cabello y/o del cuero cabelludo.
WO2003061699A1 (en) * 2001-12-27 2003-07-31 Japan Tobacco, Inc. Remedies for allergic diseases
NZ535349A (en) 2002-03-08 2007-01-26 Signal Pharm Inc JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular
JP2004182674A (ja) 2002-12-05 2004-07-02 Kureha Chem Ind Co Ltd バニリル脂肪酸アミドを含む抗腫瘍医薬組成物
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
ITMI20041566A1 (it) * 2004-07-30 2004-10-30 Indena Spa "trpv1 agonisti, formulazioni che li contengono e loro usi"
JP2010535238A (ja) 2007-07-30 2010-11-18 オールトランツ インコーポレイティド カンナビジオールのプロドラッグ、カンナビジオールのプロドラッグを含む組成物及びその使用方法
CN102186459A (zh) 2009-09-07 2011-09-14 晶源集团股份责任有限公司 含有超微粒化十六酰胺乙醇的组合物
ES2362769B1 (es) * 2009-12-24 2012-05-22 Fundació Imim Derivados de amida de ácidos grasos con anfetaminas para el tratamiento de desórdenes alimenticios.
ES2700213T3 (es) * 2010-11-08 2019-02-14 Epitech Group S P A Preparación farmacológica para uso tópico que contiene N-palmitoil-vainillamida
AU2014350912B2 (en) * 2013-11-14 2017-07-27 Zhejiang Hisun Pharmaceutical Co., Ltd. Disaccharide intermediate and synthesis method thereof
US20190290609A1 (en) * 2014-03-19 2019-09-26 Epitech Group S.P.A. Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
ES2575231B1 (es) * 2014-11-24 2017-04-06 Fundación Pública Andaluza Para La Investigación De Málaga En Biomedicina Y Salud (Fimabis) Amidas de ácidos grasos para la prevención y/o tratamiento de la esteatohepatitis.
EP3417846A1 (de) * 2017-06-19 2018-12-26 Gifar Srl Nahrungsmittel und/oder nutrazeutische zusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3156240B2 (ja) * 1991-03-20 2001-04-16 小川香料株式会社 カプサイシノイド配糖体
CA2103367A1 (en) 1991-05-20 1992-11-21 Akihide Koda Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
IT1271266B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
JPH1025237A (ja) * 1996-07-10 1998-01-27 Kanebo Ltd 外用組成物

Also Published As

Publication number Publication date
DE69904490T2 (de) 2003-10-30
IT1302264B1 (it) 2000-09-05
EP1115392B1 (de) 2002-12-11
ITMI982064A1 (it) 2000-03-24
DE69904490D1 (de) 2003-01-23
US7244767B2 (en) 2007-07-17
US20050065216A1 (en) 2005-03-24
WO2000016756A2 (en) 2000-03-30
EP1115392A2 (de) 2001-07-18
ES2189489T3 (es) 2003-07-01
WO2000016756A3 (en) 2000-09-08
AU6086099A (en) 2000-04-10

Similar Documents

Publication Publication Date Title
ATE229330T1 (de) Verwendung von n-acylvanillinamid-derivaten als agonisten der peripheren cannabinoid-cb1- rezeptoren
BR0115580A (pt) Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2
AU2003246811A1 (en) Terphenyl derivatives, preparation thereof, compositions containing same
ATE287408T1 (de) Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
MXPA04004457A (es) Novedosos derivados de 1,2,4-tiadiazolio como moduladores del receptor de melanocortina.
ATE290529T1 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
DE69318854D1 (de) Spiroazacyclischderivate als substanz p antagonisten
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DE69329727D1 (de) Neue imidazol derivate, ihre herstellung und therapeutische verwendung
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
ATE270663T1 (de) Trizyklische 1-benzylpyrazol-3- carbonsäurederivate als cannabinoidrezeptorantagonisten
DE60117594D1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
EA200200727A1 (ru) Новые производные индола
ATE441642T1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
ATE191465T1 (de) Carbamoylcarbonsäureamide
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
DK1178985T3 (da) Substituerede thienocycloalk(en)ylamino-1,3,5-triaziner
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo
FI971831A0 (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
ATE227287T1 (de) Derivate des benzopyrans und des benzothiopyrans, deren herstellung und deren verwendung als agonisten von dopamin rezeptoren
TR200402685T4 (tr) Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties